Cargando…

Quality of life after prostate cancer treatments in patients comparable at baseline

BACKGROUND: Previous studies on the effects of different prostate cancer treatments on quality of life, were confounded because patients were not comparable. This study examined treatment effects in more comparable groups. METHODS: From 2008–2011, 240 patients with localised prostate cancer were sel...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Tol-Geerdink, J J, Leer, J W H, van Oort, I M, van Lin, E J N T, Weijerman, P C, Vergunst, H, Witjes, J A, Stalmeier, P F M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658523/ https://www.ncbi.nlm.nih.gov/pubmed/23612450 http://dx.doi.org/10.1038/bjc.2013.181

Ejemplares similares

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma
por: Cella, D, et al.
Publicado: (2012)

Quality of life in participants of a CRC screening program
por: Kapidzic, A, et al.
Publicado: (2012)

Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA Initiative
por: Cuypers, Maarten, et al.
Publicado: (2019)

Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
por: van den Bergh, K A M, et al.
Publicado: (2010)

The impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapy
por: Bantema-Joppe, E J, et al.
Publicado: (2015)

Assessment of Nutritional Status, Digestion and Absorption, and Quality of Life in Patients with Locally Advanced Pancreatic Cancer
por: Witvliet-van Nierop, J. E., et al.
Publicado: (2017)

The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate—a long-term follow-up comparison and quality of life analysis
por: Dijkstra, Siebren, et al.
Publicado: (2016)

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
por: Westdorp, Harm, et al.
Publicado: (2020)

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
por: Willemse, P M, et al.
Publicado: (2013)

Baseline tumour measurements predict survival in advanced non-small cell lung cancer
por: Gerber, D E, et al.
Publicado: (2013)

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)
por: van Herpen, C M L, et al.
Publicado: (2010)

Impact of sentinel node biopsy on long-term quality of life in breast cancer patients
por: De Gournay, E, et al.
Publicado: (2013)

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial
por: Määttänen, L, et al.
Publicado: (2007)

Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial
por: Wu, C-W, et al.
Publicado: (2008)

Impact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case Series
por: Foltynie, T., et al.
Publicado: (2013)

NEAT: National Epirubicin Adjuvant Trial – toxicity, delivered dose intensity and quality of life
por: Earl, H M, et al.
Publicado: (2008)

Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial
por: van der Meulen, I C, et al.
Publicado: (2014)

Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life
por: Jeppesen, P. B., et al.
Publicado: (2009)

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation
por: van Roosmalen, M S, et al.
Publicado: (2004)

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
por: Heijnsdijk, E A M, et al.
Publicado: (2009)

The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
por: de Kok, I M C M, et al.
Publicado: (2009)

The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial
por: Arnold, D T, et al.
Publicado: (2015)

Baseline psychosocial predictors of survival in localised breast cancer
por: Lehto, U-S, et al.
Publicado: (2006)

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy
por: van der Meer, Pim B., et al.
Publicado: (2018)

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
por: Berney, D M, et al.
Publicado: (2009)

False-positive screening results in the Finnish prostate cancer screening trial
por: Kilpeläinen, T P, et al.
Publicado: (2010)

Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α
por: Yang, S, et al.
Publicado: (2010)

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer
por: Thuret, R, et al.
Publicado: (2005)

Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer
por: Klinkhammer-Schalke, M, et al.
Publicado: (2012)

Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial
por: Schneider, T. C., et al.
Publicado: (2015)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia
por: Cheng, S, et al.
Publicado: (2011)

Modifiable and fixed factors predicting quality of life in people with colorectal cancer
por: Gray, N M, et al.
Publicado: (2011)

Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006)

Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants, and associations with quality of life
por: Jansen, L, et al.
Publicado: (2011)

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial
por: Privé, Bastiaan M., et al.
Publicado: (2020)

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study
por: Baas, P, et al.
Publicado: (2006)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Protocol for the development of a Core Outcome Set (COS) for hemorrhoidal disease: an international Delphi study
por: van Tol, R. R., et al.
Publicado: (2017)

The impact of radiotherapy late effects on quality of life in gynaecological cancer patients
por: Barker, C L, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_prjs3d4apl91sv7q65l1ram1aq